Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Thomas Walter, David Malka, Olivia Hentic, Catherine Lombard‐Bohas, Karine Le Malicot, Denis Smith, Aurélie Ferru, Éric Assenat, Guillaume Cadiot, Astrid Lièvre,

Digestive and Liver Disease · 2017 · 21 citations · 17 references

Concepts

References

17